)
MetaVia (MTVA) investor relations material
MetaVia Emerging Growth Virtual Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Market opportunity and industry landscape
Cardiometabolic diseases, especially obesity and MASH, represent rapidly expanding markets, with obesity projected to reach $80–$130 billion and MASH $20–$35 billion annually worldwide.
Combination therapies are expected to dominate the MASH market, with a focus on add-on treatments to existing standards like resmetirom and GLP-1s.
Obesity prevalence exceeds 650 million adults globally, and MASH affects 5–6% of adults, often overlapping with obesity and diabetes.
Clinical development and data highlights
DA-1726, an oxyntomodulin analog, showed -9.1% weight loss and -3.8 inches waist reduction in 8 weeks at 48 mg, with dose-dependent efficacy and mild to moderate side effects.
Phase I titration studies are ongoing, with higher doses (up to 64 mg) planned to further improve efficacy and safety, targeting data release by end of 2026.
Vanoglipel (DA-1241) met primary endpoints in phase IIA for presumed MASH, showing significant hepatic and glycemic improvements, with more data expected mid-year.
Competitive positioning and differentiation
DA-1726 demonstrates early efficacy and safety signals comparable to or exceeding other GLP-1/glucagon and triple agonist therapies in early-stage trials.
Unique 3:1 GLP-1 to glucagon ratio offers superior glycemic control and weight loss potential versus competitors, with a favorable safety profile.
Adverse events, mainly mild to moderate vomiting and nausea, are expected to decrease with titration, potentially improving over competitors’ profiles.
Next MetaVia earnings date
Next MetaVia earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage